NCT04164069
- Conditions
- Advanced Colorectal Carcinoma, Bile Duct Cancer, Bile Duct Diseases, +41 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Advanced Colorectal Carcinoma
Explore clinical trials studying Advanced Colorectal Carcinoma. Study availability and eligibility vary by location and protocol.
17 public trials
7 recruiting studies
Advanced Colorectal Carcinoma trial results
Completed
Phase I FOLFOX Combination
NCT00499850
- Conditions
- Adenocarcinoma, Advanced Colorectal Carcinoma, Carcinoma, +3 more
- Locations
-
- Research Site East Melbourne, Australia
- Research Site Footscray, Australia
- Research Site Heidelberg, Australia
- Research Site Parkville, Australia
NCT01277406
- Conditions
- Advanced Colorectal Carcinoma, Colonic Diseases, Colorectal Neoplasms, +9 more
- Locations
-
- KTB-Klinik für Tumorbiologie, Klinik für Internistische Onkologie Freiburg im Breisgau, Germany
- University of Heidelberg Heidelberg, Germany
- Universitaetsklinikum Tuebingen; Med. Klinik und Poliklinik II Tübingen, Germany
NCT01208194
- Conditions
- Advanced Colorectal Carcinoma
- Locations
-
- Klinik für Innere Medizin I, Abteilung für Klinische Onkologie, Medizinische Universität Wien Vienna, Austria
- Oncology Clinic, Faculty Hospital Olomouc Olomouc, Czechia
- Service de Cancérologie Digestive, Institut de Cancérologie Gustave Roussy Villejuif, France
- Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
Active, Not Recruiting
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
NCT04535401
- Conditions
- Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma, +24 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
Active, Not Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
NCT02983578
- Conditions
- Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States